Continuing Education Company 11th Annual Diabetes, Obesity & Metabolic Disease Conference 2026
Advanced Updates in Diabetes, Obesity, Cardiometabolic Health & Metabolic Disease Management
The 11th Annual Diabetes, Obesity & Metabolic Disease Conference 2026 is a comprehensive educational program designed to provide healthcare professionals with the latest evidence-based strategies for managing diabetes, obesity, dyslipidemia, hypertension, and other cardiometabolic disorders. Hosted by Continuing Education Company, this conference brings together nationally recognized experts to discuss evolving treatment paradigms, emerging therapies, and practical approaches to improving long-term metabolic health.
Held in New Orleans, Louisiana, the conference focuses on the growing global burden of cardiometabolic disease and provides clinicians with actionable recommendations for risk assessment, prevention, lifestyle intervention, pharmacologic management, and obesity treatment. Participants gain practical knowledge that can be immediately applied in outpatient and primary care settings.
The curriculum emphasizes a multidisciplinary approach that integrates endocrinology, cardiology, obesity medicine, nutrition, preventive care, and metabolic disease management.
Product Details
- Course: 11th Annual Diabetes, Obesity & Metabolic Disease Conference
- Provider: Continuing Education Company
- Dates: May 1–3, 2026
- Location: Sheraton New Orleans, Louisiana
- Course Year: 2026
- Format: Conference Recordings
Program Overview
This conference delivers practical updates on modern cardiometabolic medicine.
Key areas of focus include:
- Type 2 Diabetes
- Obesity Medicine
- Metabolic Syndrome
- Cardiovascular Risk Reduction
- Dyslipidemia
- Hypertension
- Nutrition & Lifestyle Medicine
- Weight Management
- Preventive Cardiology
- GLP-1 Receptor Agonists
- Dual Incretin Therapies
- Cardiometabolic Disease
- Bariatric Medicine
- Population Health
Participants receive evidence-based recommendations designed to improve clinical outcomes and reduce long-term complications.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Identify and assess major cardiometabolic risk factors.
- Diagnose and manage diabetes, obesity, hypertension, and dyslipidemia.
- Implement current clinical guidelines for cardiometabolic disease prevention and treatment.
- Apply individualized treatment strategies based on patient risk profiles.
- Incorporate lifestyle interventions and nutrition counseling into patient care.
- Utilize pharmacologic and surgical treatment options when appropriate.
- Reduce long-term cardiovascular and metabolic complications.
- Improve patient outcomes through evidence-based management strategies.
Core Topics Covered
Diabetes Management
The conference reviews contemporary approaches to:
- Type 2 diabetes treatment
- Glycemic control
- Diabetes complications
- Cardiovascular risk reduction
- Kidney protection strategies
- Evidence-based medication selection
Participants gain practical guidance for managing complex diabetic patients.
Obesity Medicine
Dedicated sessions focus on:
- Obesity pathophysiology
- Medical weight loss therapies
- Lifestyle intervention programs
- Behavioral modification
- Long-term weight maintenance
- Obesity-related complications
Faculty discuss emerging therapies transforming obesity care.
Cardiometabolic Risk Reduction
Topics include:
- Cardiovascular disease prevention
- Metabolic syndrome
- Insulin resistance
- Risk stratification
- Preventive medicine strategies
Participants learn how to address interconnected cardiometabolic disorders comprehensively.
Dyslipidemia
Sessions review:
- Lipid management guidelines
- Statin therapy
- Non-statin therapies
- ASCVD risk assessment
- Hypertriglyceridemia management
Experts discuss practical approaches to improving cardiovascular outcomes.
Hypertension Management
The curriculum covers:
- Hypertension diagnosis
- Blood pressure targets
- Lifestyle interventions
- Medication selection
- Cardiovascular risk reduction strategies
Current evidence-based recommendations are emphasized.
Nutrition & Lifestyle Medicine
Participants explore:
- Medical nutrition therapy
- Dietary approaches for diabetes and obesity
- Physical activity recommendations
- Behavioral counseling techniques
- Sustainable lifestyle interventions
Practical tools are provided for patient counseling and long-term success.
Pharmacologic Therapies
Important updates include:
- GLP-1 receptor agonists
- Dual incretin therapies
- SGLT2 inhibitors
- Anti-obesity medications
- Combination treatment approaches
Faculty review efficacy, safety, and patient selection considerations.
Surgical & Advanced Interventions
Topics include:
- Bariatric surgery
- Metabolic surgery
- Patient selection criteria
- Long-term outcomes
- Postoperative management
The role of surgical intervention within comprehensive metabolic care is discussed.
Educational Features
✔ Evidence-Based Diabetes Updates
✔ Obesity Medicine Advances
✔ Cardiometabolic Disease Management
✔ Nutrition & Lifestyle Medicine Strategies
✔ Current Clinical Guidelines
✔ Emerging Pharmacologic Therapies
✔ Cardiovascular Risk Reduction Focus
✔ Practical Outpatient Management Approaches
Target Audience
This course is ideal for:
- Endocrinologists
- Cardiologists
- Internal Medicine Physicians
- Family Medicine Physicians
- Primary Care Physicians
- Obesity Medicine Specialists
- Nurse Practitioners
- Physician Assistants
- Advanced Practice Providers
- Pharmacists
- Healthcare Professionals Managing Cardiometabolic Disease
Why This Course Stands Out
✔ Dedicated focus on diabetes, obesity, and metabolic disease
✔ Covers the latest cardiometabolic treatment guidelines
✔ Strong emphasis on practical clinical application
✔ Reviews rapidly evolving obesity pharmacotherapy
✔ Integrates cardiovascular and metabolic risk management
✔ Evidence-based lifestyle and nutrition strategies
✔ Designed for both specialists and primary care clinicians
✔ Immediate relevance to everyday patient care
Clinical & Educational Value
The 11th Annual Diabetes, Obesity & Metabolic Disease Conference 2026 provides clinicians with a comprehensive review of modern cardiometabolic medicine. Through expert-led presentations and evidence-based discussions, participants gain practical knowledge on diabetes care, obesity treatment, cardiovascular risk reduction, nutrition, hypertension, dyslipidemia, and emerging therapies. The course equips healthcare professionals with the tools necessary to improve patient outcomes and address the growing burden of metabolic disease.
+ Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
- Day 1, May 1, 2026
- Day 2, May 2, 2026
- Day 3, May 3, 2026
* Detail:
FRIDAY, May 1, 2026
| Day 1: Diabetes, Cardio-Renal Disease Management with Cases, and MASLD/MASH with Case Studies | ||
| 7:50 am – 8:00 am | Welcome | A. Mullins, CHCP & J. Basile, MD |
| 8:00 am – 8:45 am | A Holistic Person-Centered Approach to Type 2 Diabetes Care | V. Aroda, MD |
| 8:45 am – 9:30 am | The Cardiovascular-Kidney-Metabolic Health Construct: Moving Away from Silos | J. Rangaswami, MD |
| 9:30 am BREAK | ||
| 9:45 am – 10:30 am | Exploration of Gut Hormone Drugs: Current Status and Pipeline | V. Aroda, MD |
| 10:30 am – 11:15 am | Combination Therapies in Kidney Disease: Saving Lives, Hearts, and Kidneys | J. Rangaswami, MD |
| 11:15 am – 11:30 am | Questions for Faculty | J. Rangaswami, MD & V. Aroda, MD |
| 11:30 am – 12:30 pm | Cases in Diabetes, Renal, and Cardio-Kidney Metabolic Disease | J. Rangaswami, MD & V. Aroda, MD |
| 12:30 pm LUNCH BREAK (Working Lunch) | ||
| 12:30 pm – 1:45 pm | Early identification and Management of Individuals At-Risk for MASH | F. Bril, MD |
| 1:45 pm – 2:45 pm | Clinical Decision Making in MASLD/MASH: A Case-Based Approach | F. Bril, MD |
SATURDAY, May 2, 2026
| Day 2: Comprehensive Obesity Management | ||
| 7:40 am – 7:45 am | Welcome | A. Mullins, CHCP |
| 7:45 am – 8:00 am | Day One Review | J. Basile, MD |
| 8:00 am – 8:45 am | New Ways of Thinking About Obesity | D. Ryan, MD |
| 8:45 am – 9:30 am | Obesity: A Practical Guide to Diagnosis, Staging, and Front-Line Therapies | C. Still, MD |
| 9:30 am BREAK | ||
| 9:45 am – 10:30 am | Metabolic and Bariatric Surgery: Is it Still an Option? | C. Still, MD |
| 10:30 am – 11:15 am | Incretins and Nutrient Stimulating Hormone Targeted Meds – Weight Loss and Beyond | D. Ryan, MD |
| 11:15 am – 11:30 am | Questions for the Faculty | D. Ryan, MD & C. Still, MD |
| 11:30 am – 12:30 pm | Cases in Obesity Management | D. Ryan, MD & C. Still, MD |
SUNDAY, May 3, 2026
| Day 3: Hypertension and Dyslipidemia Management with Case Studies | ||
| 7:40 am – 7:45 am | Welcome | A. Mullins, CHCP |
| 7:45 am – 8:00 am | Day Two Review | J. Basile, MD |
| 8:00 am – 9:00 am | Clinical Pearls in Outpatient HTN: What’s New in the 2025 HTN Guideline | J. Basile, MD |
| 9:00 am – 10:00 am | The 2026 Updated ACC/AHA Dyslipidemia Guideline: What’s New, What’s Not | L. Sperling, MD |
| 10:00 am BREAK | ||
| 10:15 am – 11:00 am | Focus on Lipid-Related Risk as a Component of Comprehensive Cardio-Kidney-Metabolic Health | L. Sperling, MD |
| 11:00 am – 11:15 am | Questions for the Faculty | J. Basile, MD & L. Sperling, MD |
| 11:15 am – 12:15 pm | Cases on HTN and Lipids | J. Basile, MD & L. Sperling, MD |









